[Cardiorenal syndrome by heart failure]

Area of Science:

• Cardiology
• Nephrology
• Internal Medicine

Background:

• Cardiorenal (CR) syndrome is characterized by primary cardiac dysfunction leading to renal hemodynamic failure.
• Heart failure reduces cardiac output, activating vasoconstrictors that decrease renal perfusion and glomerular filtration, ultimately causing renal failure.

Purpose of the Study:

• To analyze the pathophysiological mechanisms of CR syndrome.
• To examine patient characteristics, medication roles, and the interplay of proteinuria and anemia in CR syndrome.
• To evaluate the prognostic value of biomarkers and pulmonary hypertension in CR syndrome patients.

Main Methods:

• Literature review and analysis of pathophysiological mechanisms.
• Examination of clinical characteristics and therapeutic interventions.
• Investigation of the relationship between proteinuria, anemia, biomarkers, and pulmonary hypertension in CR syndrome.

Main Results:

• Primary cardiac dysfunction precipitates renal hemodynamic compromise in CR syndrome.
• Reduced renal perfusion, vasoconstriction, and decreased glomerular filtration are key features.
• Proteinuria, anemia, specific biomarkers, and pulmonary hypertension are significant prognostic indicators.

Conclusions:

• Understanding CR syndrome pathophysiology is crucial for patient management.
• Therapeutic strategies must address both cardiac and renal components.
• Biomarkers and pulmonary hypertension assessment aid in predicting outcomes for CR syndrome patients.